Risk of disease flares after SARS-CoV-2 mRNA vaccination in patients with systemic lupus erythematosus
Description
This study aims to elucidate the effectiveness and safety of SARS-CoV-2 mRNA vaccination in patients with systemic lupus erythematosus (SLE). We enrolled uninfected SLE patients who received two vaccine doses (BNT162b2 or mRNA-1273) and historical
